📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

An observational study of alemtuzumab following fingolimod for multiple sclerosis. (2017)

First Author: Willis M

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000000320

PubMed Identifier: 28101520

Publication URI: http://europepmc.org/abstract/MED/28101520

Type: Journal Article/Review

Volume: 4

Parent Publication: Neurology(R) neuroimmunology & neuroinflammation

Issue: 2

ISSN: 2332-7812